Abstract 962: Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer

Abstract Introduction: Phenylacetaldehyde (PAA), a product of phenylalanine metabolism, is generated by microbiota and has demonstrated anticancer properties in breast cancer. As intestinal homeostasis is influenced by the gut microbiome, we investigated the effect of PAA on colorectal cancer (CRC). Methods: Serum PAA levels and feces microbiota from a test cohort of 30 CRC patients and 30 healthy control patients were analyzed by targeted GC-MS/MS and metagenomic sequencing. A validation cohort of 75 CRC patients and 53 healthy control patients was analyzed for PAA levels in serum. CRC cell lines and CRC-patient-derived organoids were cultured and treated with PAA alone or in combination with 5-fluorouracil (5-FU), then evaluated for viability, proliferation, , and cell death in vitro. The effect of PAA alone or in combination with 5-FU on tumor growth was also tested in vivo. We identified the mechanisms induced by PAA treatment using RNA sequencing, western blot, immunostaining, ROS quantification assay, cysteine and glutathione quantification. Results: PAA levels were significantly decreased in the circulation of CRC patients compared to healthy controls in our study population and the validation cohort. Metagenomic sequencing indicated the bacteria that positively correlated with PAA levels were significantly more abundant in healthy controls; while bacteria that negatively correlated with PAA were more abundant in CRC. In vitro, PAA inhibited the viability and colony formation of CRC cell lines as well as human-derived organoids in a concentration-dependent manner. Mechanistically, PAA treatment induced generation of ROS leading to cysteine and reduced glutathione depletion. An investigation by RNA sequencing and immunoblotting showed that PAA inhibits CRC by inducing endoplasmic reticulum stress-induced autophagy accompanied by downregulation in PI3K/AKT/mTOR and ERK pathways. When combined with 5-FU, PAA enhanced the potency of 5-FU on viability, cell death, DNA damage and tumor growth. Conclusions: The bacteria metabolite PAA increased CRC cell death by endoplasmic reticulum stress-induced autophagy and downregulation of the PI3K/AKT/mTOR and ERK pathways. PAA also potentiated the chemotherapeutic efficacy of 5-FU through induction of DNA damages. These findings warrant further exploration of PAA as a potential CRC biomarker and novel therapeutic agent. Citation Format: Sylvain Ferrandon, Cheng Kong, Joseph sara soltani tehrani, Fedro, Rami-James Aoun, Zeneng Wang, Chureeporn Chitchumroonchokchai, Huanlong Qin, Steve Clinton, Matthew F. Kalady. Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 962.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-962
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 962: Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer

S. Clinton, Sylvain Ferrandon, Zeneng Wang, Cheng Kong et al.
Cancer Research
Colorectal Cancer Treatments and Studies
article

Abstract 962: Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer

S. Clinton, Sylvain Ferrandon, Zeneng Wang, Cheng Kong, Chureeporn Chitchumroonchokchai, Joseph Fedro, Rami-James Aoun, Sara Soltani Tehrani, Matthew F. Kalady
article en

Abstract

Abstract Introduction: Phenylacetaldehyde (PAA), a product of phenylalanine metabolism, is generated by microbiota and has demonstrated anticancer properties in breast cancer. As intestinal homeostasis is influenced by the gut microbiome, we investigated the effect of PAA on colorectal cancer (CRC). Methods: Serum PAA levels and feces microbiota from a test cohort of 30 CRC patients and 30 healthy control patients were analyzed by targeted GC-MS/MS and metagenomic sequencing. A validation cohort of 75 CRC patients and 53 healthy control patients was analyzed for PAA levels in serum. CRC cell lines and CRC-patient-derived organoids were cultured and treated with PAA alone or in combination with 5-fluorouracil (5-FU), then evaluated for viability, proliferation, , and cell death in vitro. The effect of PAA alone or in combination with 5-FU on tumor growth was also tested in vivo. We identified the mechanisms induced by PAA treatment using RNA sequencing, western blot, immunostaining, ROS quantification assay, cysteine and glutathione quantification. Results: PAA levels were significantly decreased in the circulation of CRC patients compared to healthy controls in our study population and the validation cohort. Metagenomic sequencing indicated the bacteria that positively correlated with PAA levels were significantly more abundant in healthy controls; while bacteria that negatively correlated with PAA were more abundant in CRC. In vitro, PAA inhibited the viability and colony formation of CRC cell lines as well as human-derived organoids in a concentration-dependent manner. Mechanistically, PAA treatment induced generation of ROS leading to cysteine and reduced glutathione depletion. An investigation by RNA sequencing and immunoblotting showed that PAA inhibits CRC by inducing endoplasmic reticulum stress-induced autophagy accompanied by downregulation in PI3K/AKT/mTOR and ERK pathways. When combined with 5-FU, PAA enhanced the potency of 5-FU on viability, cell death, DNA damage and tumor growth. Conclusions: The bacteria metabolite PAA increased CRC cell death by endoplasmic reticulum stress-induced autophagy and downregulation of the PI3K/AKT/mTOR and ERK pathways. PAA also potentiated the chemotherapeutic efficacy of 5-FU through induction of DNA damages. These findings warrant further exploration of PAA as a potential CRC biomarker and novel therapeutic agent. Citation Format: Sylvain Ferrandon, Cheng Kong, Joseph sara soltani tehrani, Fedro, Rami-James Aoun, Zeneng Wang, Chureeporn Chitchumroonchokchai, Huanlong Qin, Steve Clinton, Matthew F. Kalady. Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 962.

Cancer ResearchVol. 86(7_Supplement)
Cleveland Clinic Lerner College of Medicine (US), Fudan University Shanghai Cancer Center (CN), Shanghai Tenth People's Hospital (CN), The Ohio State University (US)
Good health and well-being
Openalex Percentile: Top 20%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.